CSL

CSL Seqirus CSL plant Melbourne Australia CSL Seqiris plant flu shot plant influenza
Manufacturing

Its future murky, CSL Seqirus opens $1B vax plant in Australia

CSL Seqirus has opened the doors to a new $1 billion cell-based influenza vaccine and antivenom facility in Melbourne.
Joseph Keenan Dec 9, 2025 9:08am
Gene

ASH: CSL proves 5-year durability of Hemgenix

Dec 7, 2025 12:00pm
CSL Behring

CSL earmarks $1.5B for US production expansion over next 5 years

Nov 18, 2025 7:56am
unlabeled vaccine

CSL unit enters Saudi Arabian flu shot production, supply pact

Oct 30, 2025 1:11pm
yellow light street light traffic pause slow delay

CSL delays vax unit spinoff as US immunization rates plummet

Oct 28, 2025 10:00am
workers

Vifor to cut 55 staffers in Pa. amid CSL downsizing effort

Oct 8, 2025 10:45am